MedTrace Logo

Evaluation of Efficacy and Safety of the triLift™ System

NCT05773924 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-03-17

No results posted yet for this study

Summary

Single center, single-arm, prospective, open Label with Before \& After Study Design.

Conditions

  • Skin Laxity
  • Wrinkle

Interventions

DEVICE

triLift system

To evaluate the efficacy of the triLift™ treatment

Sponsors & Collaborators

  • Lumenis Be Ltd.

    lead INDUSTRY

Principal Investigators

  • Arielle Kauvar, MD · New York Laser & Skin Care

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2023-08-15
Completion
2023-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05773924 on ClinicalTrials.gov